Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 79.89B | 84.19B | 73.69B | 61.03B | 56.90B | 54.87B |
Gross Profit | 15.63B | 17.14B | 12.69B | 9.54B | 9.08B | 7.91B |
EBITDA | 8.73B | 10.54B | 6.16B | 3.52B | 3.38B | 2.06B |
Net Income | 6.12B | 7.26B | 4.51B | 2.34B | 2.24B | 1.23B |
Balance Sheet | ||||||
Total Assets | 72.88B | 80.16B | 76.23B | 63.46B | 63.70B | 62.44B |
Cash, Cash Equivalents and Short-Term Investments | 10.04B | 12.77B | 10.02B | 13.26B | 14.87B | 14.82B |
Total Debt | 840.00M | 65.00M | 125.00M | 65.00M | 165.00M | 121.00M |
Total Liabilities | 22.22B | 27.21B | 27.05B | 20.08B | 21.24B | 21.16B |
Stockholders Equity | 50.66B | 52.95B | 49.18B | 43.37B | 42.46B | 41.28B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 4.45B | -1.85B | -359.00M | 615.00M | 675.00M |
Operating Cash Flow | 0.00 | 4.65B | -1.45B | -157.00M | 904.00M | 1.14B |
Investing Cash Flow | 0.00 | -159.00M | -340.00M | -625.00M | -130.00M | -1.29B |
Financing Cash Flow | 0.00 | -1.79B | -1.72B | -883.00M | -565.00M | -1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥75.77B | 9.69 | 2.53% | 4.24% | 22.05% | ||
81 Outperform | ¥99.45B | 12.48 | 2.03% | 17.42% | 83.57% | ||
77 Outperform | ¥150.41B | 13.64 | 3.10% | 9.14% | 43.46% | ||
76 Outperform | ¥52.03B | 11.87 | 2.22% | 10.35% | 152.81% | ||
74 Outperform | ¥15.13B | 9.26 | 4.07% | 33.76% | ― | ||
74 Outperform | ¥101.87B | 15.51 | 2.07% | 7.26% | 29.33% | ||
61 Neutral | C$7.19B | -4.76 | -4.20% | 2.32% | 13.56% | -31.48% |